11/08/2024
7:02 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:01 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
2:13 PM | JANUS HENDERSON GROUP PLC (Filed by)
Monopar Therapeutics (Subject)
| Form SC 13G | |
10/31/2024
3:17 PM | Monopar Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
10/28/2024
3:04 PM | Monopar Therapeutics (Filer)
| Form 424B5 | |
10/28/2024
5:00 AM | ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
Monopar Therapeutics (Subject)
| Form SC 13G | |
10/24/2024
3:08 PM | Monopar Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
|
10/24/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
6:45 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
6:44 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:07 PM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
7:01 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
7:02 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/22/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form DEF 14A | |
07/22/2024
6:01 AM | Monopar Therapeutics (Filer)
| Form ARS | |
07/11/2024
3:30 PM | Monopar Therapeutics (Filer)
| Form PRE 14A | |
07/09/2024
3:01 PM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
5:20 PM | Monopar Therapeutics (Issuer)
Radhakrishnan Karthik (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2024
5:22 PM | Monopar Therapeutics (Issuer)
Radhakrishnan Karthik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:07 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:08 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:12 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:16 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
5:08 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:30 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
5:12 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:56 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:10 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/16/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
7:33 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Tesla Execs are Freaking Out (Ad) It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it.
And Elon Musk has completely restructured Tesla to chase this opportunity.
This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. |
04/02/2024
7:33 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
7:35 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
6:01 AM | Monopar Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2024
7:30 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
12:45 PM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
5:59 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
6:36 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:37 PM | Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:38 PM | KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:39 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:40 PM | Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:40 PM | Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:33 PM | Monopar Therapeutics (Issuer)
RIOUX PATRICE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:34 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free MNPR Stock Alerts